Demonstrating Robustness & Phenotypic Diversity with OmniVUE™: A Customizable Multiplex Immunofluorescence Platform
Time: 1:45 pm
day: Conference Day 1- Part 2
Details:
- The new OmniVUE platform provides a highly customizable solution, offering up to 12-plex configurations from a validated menu of 24 biomarkers, with an expansion to 30 markers underway
- We conducted a comprehensive assay verification to assess the performance of a 12-plex panel assembled from Ultivue’s pre-validated marker menu
- The platform’s ability to detect multiple phenotypes in a single tissue section was demonstrated by targeting 12 distinct markers, including T-cell, macrophage, and tumor markers. The results showed that marker performance remained unaffected by the order of staining rounds, underscoring the flexibility and reliability of OmniVUE’s multiplexing approach
